{
    "clinical_study": {
        "@rank": "146508", 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the safety and effectiveness of two dosage schedules\n      for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis"
        }, 
        "brief_title": "A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis", 
        "condition": [
            "Cytomegalovirus Retinitis", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Retinitis", 
                "Cytomegalovirus Retinitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a multicenter, prospective, randomized, open-label study comparing 2 dosage\n      schedules of ISIS 2922."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Oral ganciclovir.\n\n          -  Leukocyte growth factors (GM-CSF and G-CSF) for patients with febrile neutropenia.\n\n        Patients must have:\n\n          -  Documented AIDS.\n\n          -  Clinical diagnosis of advanced CMV retinitis in 1 or both eyes.\n\n          -  >= 2 previous induction courses with anti-CMV retinitis therapy licensed by a\n             regulatory agency.\n\n          -  > 25% retinal involvement with CMV retinitis.\n\n          -  Baseline CMV retinitis lesions which have leading edges > 1000 micrograms from the\n             macula or optic disk.\n\n        Prior Medication:\n\n        Required:\n\n          -  >= 2 previous induction courses with anti-CMV retinitis therapy licensed by a\n             regulatory agency.\n\n        Allowed:\n\n          -  All anti-CMV therapies other than ganciclovir must be discontinued no less than 2\n             days prior to entry.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms and conditions are excluded:\n\n          -  External ocular infection in the eye to be treated.\n\n          -  Other herpetic infections of the retina, toxoplasma, retinochoroiditis, or other\n             disease of the fundus that would preclude assessment of CMV retinitis in the eye to\n             be treated.\n\n          -  Ocular conditions that will obstruct visualization of the posterior ocular structures\n             on the eye to be treated.\n\n          -  Retinal detachment in the eye to be treated.\n\n          -  Ganciclovir implant in the eye to be treated.\n\n          -  Known or suspected allergy to phosphorothioate oligonucleotides or intolerance of\n             ISIS 2922.\n\n          -  Silicone oil in the eye to be treated.\n\n          -  Pseudoretinitis pigmentosa.\n\n          -  Syphilis.\n\n        Patients with the following prior conditions are excluded:\n\n          -  History of surgery to correct retinal detachment in the eye to be treated.\n\n          -  History of syphilis.\n\n             1. Systemic anti-CMV therapies other than oral ganciclovir.\n\n          -  Mellaril, Stelazine, chlorpromazine and clofazimine.\n\n          -  Combination use of ethambutol and fluconazole.\n\n          -  Investigational medications and/or procedures for the treatment of CMV retinitis in\n             the eye to be treated.\n\n          -  Ganciclovir implant delivery device in the eye to be treated.\n\n          -  Ganciclovir other than oral.\n\n          -  Foscarnet."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002187", 
            "org_study_id": "251D", 
            "secondary_id": "ISIS 2922-CS9"
        }, 
        "intervention": {
            "intervention_name": "Fomivirsen sodium", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Fomivirsen"
        }, 
        "keyword": [
            "AIDS-Related Opportunistic Infections", 
            "Antiviral Agents", 
            "Drug Administration Schedule", 
            "Cytomegalovirus Retinitis", 
            "fomivirsen", 
            "Vitreous Body"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90017"
                    }, 
                    "name": "Retina - Vitreous Associates Med Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pasadena", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "911052536"
                    }, 
                    "name": "Community Eye Med Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115"
                    }, 
                    "name": "Dr Jacob Lalezari"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94110"
                    }, 
                    "name": "Univ of California San Francisco / SF Gen Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20006"
                    }, 
                    "name": "Dr Alan Palestine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33060"
                    }, 
                    "name": "Dr Julio Perez"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30327"
                    }, 
                    "name": "Georgia Retina"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Univ of Illinois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60610"
                    }, 
                    "name": "Chicago Ctr for Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Indiana Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "New York Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10028"
                    }, 
                    "name": "Vitreo - Retinal Consultants"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28204"
                    }, 
                    "name": "Charlotte Eye Ear Nose & Throat Association"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "191021192"
                    }, 
                    "name": "Hahnemann Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Baylor College of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98104"
                    }, 
                    "name": "Novum Inc"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized Comparison of Two Dosage Schedules of Intravitreal ISIS 2922 for Patients With Advanced Cytomegalovirus Retinitis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "11365968", 
                "citation": "[No authors listed] New CMV drug won't replace other therapies. Aids Alert. 1998 Nov;13(11):124-6. No abstract available."
            }, 
            {
                "PMID": "11365956", 
                "citation": "Roehr B. Fomivirsen approved for CMV retinitis. J Int Assoc Physicians AIDS Care. 1998 Oct;4(10):14-6. No abstract available."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002187"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Isis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 1998"
    }, 
    "geocoordinates": {
        "Baylor College of Medicine": "29.76 -95.369", 
        "Charlotte Eye Ear Nose & Throat Association": "35.227 -80.843", 
        "Chicago Ctr for Clinical Research": "41.878 -87.63", 
        "Community Eye Med Group": "34.148 -118.145", 
        "Dr Alan Palestine": "38.895 -77.036", 
        "Dr Jacob Lalezari": "37.775 -122.419", 
        "Dr Julio Perez": "26.122 -80.143", 
        "Duke Univ": "35.994 -78.899", 
        "Georgia Retina": "33.749 -84.388", 
        "Hahnemann Univ Hosp": "39.952 -75.164", 
        "Indiana Univ Med Ctr": "39.769 -86.158", 
        "New York Univ Med Ctr": "40.714 -74.006", 
        "Novum Inc": "47.606 -122.332", 
        "Retina - Vitreous Associates Med Group": "34.052 -118.244", 
        "Univ of California San Francisco / SF Gen Hosp": "37.775 -122.419", 
        "Univ of Illinois": "41.878 -87.63", 
        "Vitreo - Retinal Consultants": "40.714 -74.006"
    }
}